Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Morning glory syndrome (MGS) is an optic neuropathy characterized by a congenital funnel shaped excavation of the posterior fundus that incorporates the optic disk malformation (resembling the morning glory flower) MGS is usually unilateral and may result in a decrease in best-corrected visual acuity (BCVA). MGS either occurs isolated or associated to other ocular or non-ocular anomalies.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for morning glory syndrome.
11 publications have been identified in PubMed for morning glory syndrome. Research spans Case Report / Case Series (40%), Clinical Trial Publication (20%), and Other (10%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 4 | 40% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 12:53 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
2 |
20% |
Other research | 1 | 10% |
Research summaries | 1 | 10% |
Disease patterns and progression | 1 | 10% |
New treatment approaches | 1 | 10% |
Wang L (2026). [PMID: 41919158](https://pubmed.ncbi.nlm.nih.gov/41919158/). *Front Med (Lausanne)*. [Case Report / Case Series]
Feng Z (2026). [PMID: 41857236](https://pubmed.ncbi.nlm.nih.gov/41857236/). *J Imaging Inform Med*. [Gene Therapy / Novel Therapeutics]
García-Bardera J (2026). [PMID: 42013736](https://pubmed.ncbi.nlm.nih.gov/42013736/). *J Fr Ophtalmol*. [Other]
Sheremet NL (2025). [PMID: 41432512](https://pubmed.ncbi.nlm.nih.gov/41432512/). *Vestn Oftalmol*. [Case Report / Case Series]
Ozdek S (2025). [PMID: 40623304](https://pubmed.ncbi.nlm.nih.gov/40623304/). *Retin Cases Brief Rep*. [Clinical Trial Publication]
Liu JC (2025). [PMID: 39562198](https://pubmed.ncbi.nlm.nih.gov/39562198/). *J Fr Ophtalmol*. [Case Report / Case Series]
Wu S (2025). [PMID: 39959883](https://pubmed.ncbi.nlm.nih.gov/39959883/). *Clin Ophthalmol*. [Review / Meta-Analysis]
Xin WJ (2025). [PMID: 40062134](https://pubmed.ncbi.nlm.nih.gov/40062134/). *Cureus*. [Case Report / Case Series]
Cen C (2025). [PMID: 40725964](https://pubmed.ncbi.nlm.nih.gov/40725964/). *Medicine (Baltimore)*. [Epidemiology / Natural History]
Özdemir Zeydanlı E (2024). [PMID: 39463152](https://pubmed.ncbi.nlm.nih.gov/39463152/). *Turk J Ophthalmol*. [Clinical Trial Publication]